Find a TenderPlanned procurementPreliminary market engagement notice
Published 28 Nov 2025, 12:17 GMT

Official UK procurement notice

Microbiology Services · UK public procurement notice

Authority: The Royal Marsden NHS Foundation Trust (Central government)·On behalf of: Central London Community Healthcare NHS Trust

ServicesAbove thresholdSME suitableVCSE suitable
Planned pipeline value£3,080,000pipeline notice, not a live tender
Tender notice expected 1 Jan 2027from the planned procurement notice
Contract term 3 yrsends 1 Jan 2031 · starts 1 Jan 2028

What is being bought

Published requirement description

The Royal Marsden is currently exploring alternative operating models for its microbiology services and is undertaking a market engagement exercise to gather insights from providers. The exercise is designed to be a fact-finding and there is no formal evaluation. Providers are encouraged to propose individual solutions on their approach to service delivery and guidance on how to structure responses is listed in the attached <Provider Response Pack>. The objective of the market engagement exercise is to inform decision making on whether to move forward with a formal tender, but this is not a guarantee at this stage. With details of contract start dates provided only as estimates in the event there is a decision to progress to tender.

Service Overview

Effective microbiology services are essential for the timely diagnosis of infections. For the oncology patient population microbiology screening, advice and guidance on treatment options and oversight of anti-microbial stewardship are also vital in ensuring individual treatments are optimised. Environmental testing provision is also in place to support cellular therapy, radiopharmacy and aseptic services. At the Royal Marsden Hospital the microbiology service consists of two discrete but collaborative functions. A UKAS accredited microbiology laboratory and a clinical microbiology service.

The microbiology laboratory is based at our Sutton site, providing microbiology testing for our Chelsea, Sutton and Cavendish Square sites. The laboratory processes approximately 187, 000 samples per year. With approximately 65% of these tests requiring a turn-around time of 24-48 hours for a positive result. <See tab 1 in the attached spreadsheet titled <RMH_Micro_Men_Supporting_Specification> for detailed breakdown.

Clinical microbiology provides a core advice and guidance function in addition to reporting of microbiology testing, oversight of the laboratory and contribution to antimicrobial stewardship ward rounds and specialty meetings. The function provides clinical leadership for the Trust’s infection prevention and control service, teaching and leadership on departmental research projects as required. For a full breakdown of key activities please refer to the second tab of the attached spreadsheet titled <RMH_Micro_Men_Supporting_Specification>

Out of hours clinically urgent testing or clinical advice and guidance is provided on agreement with the on-call clinical microbiologist, with the laboratory on-call biomedical scientist providing urgent testing as required. For a full breakdown of expected activities for the “Out of Hours” function please refer to the third tab of the attached spreadsheet titled <RMH_Micro_Men_Supporting_Specification>

The aim for the Royal Marsden Hospital is to ensure a cohesive, sustainable and cost-effective microbiology service that meets the clinical needs of our cancer patients. To that end the Trust has decided to gather information on all possible options for future service delivery and is opening up an early market engagement to explore potential provision options for one, a combination of or all of the below services:

  • In-hours core clinical microbiology services
  • Out-of-hours urgent clinical microbiology services
  • Microbiology laboratory testing services

The Trust is seeking to understand from both NHS and private sector providers proposed approaches to delivering one or all of the above listed services.

Respondents are encouraged to provide individual solutions to delivering the above-described services. Paying consideration to their approach to the following criteria:

Service Delivery

  • Meeting turnaround times for urgent and standard testing, result authorisation and advice and guidance
  • Sample transport and tracking
  • Maintaining continued UKAS accreditation
  • Resourcing and skills mix of staff to maintain day to day service resilience and long-term sustainability of the service
  • Digital inter-operability and compliance to NHS and U.K. information governance and cyber security regulations

Business Continuity

  • Long-term workforce strategy incorporating recruitment, staff development and retention
  • Robust business continuity plan to address activity surges, staff shortages, digital outages or other major incidents

Clinical Alignment

  • Adherence to RMH testing protocols and anti-microbial and infection control policies
  • Adherence to JACIE transplant Standard Operating Procedures and Human Tissue Authority licensing standards
  • Alignment with the Trust’s clinical governance framework
  • Aligning clinical decision making to RMH requirements and approaches to maintaining adherence across services i.e. Laboratory and Clinical Microbiology
  • Communication and liaison with key clinical and operational stakeholders
  • Training and development of staff
  • Ensuring up to date best practice and implementation of innovative technologies and process efficiencies

Financial Reimbursement

  • Expected financial reimbursement model e.g. reimbursement per test and staff cost estimates (laboratory and Clinical microbiology).

Directions for Respondents

As this is a market engagement exercise no formal information framework is included. To structure responses the Trust would appreciate feedback as per the format outlined in the <Provider Response Pack> within the attached documents. All questions are optional any feedback received will not be evaluated and will be used for information purposes only.

Please note that completion of the information within the pack will in no way obligate your organisation to participate in any future related tenders. Nor will it have any impact on the outcome of any future related tenders. Conversely failing to participate in the process would in no way preclude your organisation from participation in any future related tenders.

The purpose of the questionnaire is to gain a greater understanding of the market, particularly the potential for any new developments in the sector. With full confidentiality maintained throughout the exercise.

Microbiology Laboratory (Core hours and out of hours service)

Provision of a microbiology laboratory ISO15189. For the list of tests please refer to Tab 1 in the attached document titled <RMH_Micro_Men_Supporting_Specification>.

Provision of environmental testing required for the production of cellular therapy, aseptic and radiopharmaceutical products under ISO17025.

Opening Hours:

Core Hours

08:00 – 18:00 Monday to Friday

Out of hours testing

Outside above stated hours for 24 hours a day (inclusive of weekends and bank holidays)

Testing

During core hours, to provide microbiology, viral serology testing services for the tests included in the linked document, within the stated turnaround times (TaTs). (Expected TaTs are listed in Tab 1 of the attached document

<RMH_Micro_Men_Supporting_Specification>.)

Out of hours, ensure provision to liaise with on-call clinical microbiologist. Undertaking testing when deemed clinically urgent.

Transit

To accommodate sample referrals from the Royal Marsden’s Sutton, Chelsea and Cavendish Square sites. With sample collections sufficiently frequent to meet required turnaround times with adherence to UN133 sample packing and storage requirements.

Communication and prioritisation

During core hours to provide direct telephone liaison between Royal Marsden clinical staff and the laboratory.

To ensure provision is in place for urgent samples to be prioritised for processing, as and when agreed with the clinical microbiologist.

Clinical Microbiology (Core Service)

To enable sufficient clinical microbiology provision to deliver the following services from 09:00 – 17:00 Monday to Friday:

  • Advice and guidance (Urgent and General)
  • Result reporting and verification
  • Attendance at daily MDTs
  • Clinical leadership of RMH’s anti-Microbial stewardship
  • Clinical contribution to RMH’s Infection Prevention and Control agenda

For further details please refer to the Clinical Microbiology Schedule of Activities in Tab 2 of the attached document <RMH_Micro_Men_Supporting_Specification>.

Clinical Microbiology Service (Out of hours Service)

Monday to Friday (17:00 to 9:00) and for 24 hours during weekends to provide sufficient clinical microbiology provision to cover the following:

  • Reactive advice and guidance (Telephone, email and digital messaging)
  • Result reporting and verification

For more details please see Tab 3 of the attached document <RMH_Micro_Men_Supporting_Specification>.

Please note that all additional supporting documents are located under Atamis Project Ref: C404289

CPV: Pathology services

The lotProcurement structure

single lot · no lot value published
Lot #1Planned 3 yrsSMEVCSE
Contract period: 1 Jan 2028 – 1 Jan 2031 (3 yrs)
Delivery: LondonEligibility: SME eligibleVCSE eligible

Who is likely to bid for this lot ↓

Pipeline intelligence · planning stage: how this market runs before the tender is published

How The Royal Marsden NHS Foundation Trust buys Hospital and related services (CPV 8511), and who usually turns up

The Royal Marsden NHS Foundation Trust’s own published record, next to the published market for the same work. Frameworks and DPS are kept out: they attract a different number of bids. Whole-market view: Hospital and related services (CPV 8511) →

1

How the contest usually goes

Winner shares use published awards; bid and price charts use contested lots.

Question for the bidWhat to do with it
How often do SMEs win?
i

How often small and medium firms win.

Share of awards where the winner’s size is known.

The counts under this question show how many awards have a known supplier size.

Last 36 months.

Buyer: 5 of 6 known-size awards · market: CPV 8511 · Greater London, n=112
83%29%

Small firms have won here. Neither number says whether you qualify; it describes who has been winning.

How often do local suppliers win?
i

How often local firms win similar work.

Winners with a registered address in the delivery region, out of awards with a known address.

Here, local means registered in Greater London.

A local branch does not count if the registered address is elsewhere.

Last 36 months.

Buyer: 2 of 4 known-location awards · market: CPV 8511 · Greater London, n=123
2 of 476%

Most of this buyer’s recorded winners are registered in Greater London.

How long to a decision?
i

How long buyers here take to decide after bids close.

Middle value in days from the deadline to the first award notice, on competitions that published both dates.

Only decided tenders count, so slow ones still waiting are not in.

Last 36 months.

Buyer: no decision dates published · market: CPV 8511 · UK-wide, n=21
—78 days

Half of these awards were announced within 78 days of the bid deadline.

How often single-bid or direct?
i

How often work is awarded with no recorded rival.

Direct awards and tenders where every published lot count shows one bid.

Both shares are minimums: some awards have no bid count.

Thin markets produce this too; it is not proof of a tailored specification.

Last 36 months.

Buyer: at least 7 of 8 procurements with awards had no recorded rival · market: CPV 8511 · Greater London, n=159
88%73%

Direct awards or one recorded bid are common here. Check the route before spending time on a bid.

How many bids did past lots attract?

i

How many bids past lots received.

Each colour is a bid-count range. Only competed lots with a published count are included.

Past bids do not predict this tender.

Last 36 months.

This buyer2 lots with bid counts · all categories · too few to chart
The market6 lots with bid counts · CPV 8511 · Greater London
33% had one bid
Market · select a colour for counts
1 bid33%
Market: 2 of 6 lots with published bid counts.
2–350%
Market: 3 of 6 lots with published bid counts.
4–60%
Market: 0 of 6 lots with published bid counts.
7+17%
Market: 1 of 6 lots with published bid counts.

How did awards compare with estimates?

i

Where winning prices landed against estimates.

Each colour shows awards below, close to or above the published estimate, one lot at a time.

Past prices are a guide, not a bid price.

Last 36 months.

This buyer1 lot with estimate and award · all categories · too few to chart
The market34 lots with estimate and award · CPV 8511 · UK-wide
18% below estimate
Market · select a colour for counts
Below estimate18%
Market: 6 of 34 lots with an estimate and award.
Within ±2%50%
Market: 17 of 34 lots with an estimate and award.
Above estimate32%
Market: 11 of 34 lots with an estimate and award.
2

Assess each lot
i

What past awards tell you about each lot.

See the forecast, this buyer’s earlier suppliers and firms with relevant wins.

No supplier is confirmed as a bidder.

Open a lot for its forecast, this buyer’s previous supplier and possible competitors, from published award history, not a bid list

Lot #1CPV 851136 monthsSME suitablePublished estimate£3.1m
Expected competition
i

How many bids this lot may attract.

The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.

Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 478 past lots.

A forecast, not a list of bidders.

—No model forecast yet24% single-bid risk
Past bids on 478 similar lots
1 bid24%
117 of 478 similar past lots received 1 bid (24%).
2–332%
155 of 478 similar past lots received 2–3 (32%).
4–626%
124 of 478 similar past lots received 4–6 (26%).
7+17%
82 of 478 similar past lots received 7+ (17%).
Comparable past lots usually drew 3 bids.
Commercial price forecast
i

Where the award price may land.

The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.

No comparable awards for this lot yet.

A statistical guide from past awards, not a price to bid.

—No model forecast yet
No comparable awards on record for this lot’s category yet. The published estimate is £3.1m, and the forecast stays empty until the market has a record to read.

Who has supplied this buyer on similar work?
i

Who has done similar work for this buyer.

Past contracts are matched by buyer, title and type of work.

A past supplier may not bid again.

No earlier contract of this buyer matches this lot on the published record.

Who could compete for this lot?
i

Who could compete for this lot?

Firms with relevant past wins. On a framework, we show firms on that agreement.

None is confirmed as a bidder.

Candidate suppliers for this notice have not been worked out yet, so this is not a verdict that nobody fits.

About this data
  • Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
  • Two views, kept apart. The authority’s own track record and the wider market for the same kind of work sit side by side and are never mixed. Where the local picture is too thin, a figure widens to a broader market and says which one it used.
  • Forecasts are labelled. The price forecast and its range, possible competitors and the earlier-work matches are our estimates from past awards: not published facts, not win chances and not price advice. Official notices do not say who is bidding.
  • Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.

Procedure terms & legal framework

From the official record
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Services
Notice status
Planned procurement
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
28 Nov 2025, 12:17 GMT
Last source update
28 Nov 2025, 12:28 GMT
Authority reference
C404289
FTS notice number
2025/S 000-078059
Latest notice
Preliminary market engagement notice (UK2)
Classification (CPV)
Pathology services
Delivery area
London (UKI)
Official registry OCID
ocds-h6vhtk-05eafc Find a Tender

How it was run

Official notice
Submission deadline
—

Timeline

28 Nov 2025 → 1 Jan 2028 · 4 dates
  1. Planning notice published326 days ago
    28 Nov 2025, 12:17 GMT
  2. Market engagement277 days ago
    16 Jan 2026, 23:59 GMT

    The questionnaire will run on the Atamis portal: health-family.force.com/s/Welcome ↗ How to access the Questionnaire on the portal:

    • Suppliers should register on the portal, if not already registered:
    • To Express an Interest in this market engagement, search and Select contract reference - C404289

    As per the above instructions those with expressions of interest are to upload their Provider Response Pack and any additional supporting documents by 16/01/2026.

    At this stage, there will be no scheduled market engagement events. However, providers may be contacted to provide clarification on their responses in January 2026.

    Should interested parties have clarification questions in relation to this exercise. Please respond via the portal.

  3. Today
    20 Oct 2026
  4. Tender notice expectedin 73 days
    1 Jan 2027, 23:59 GMT
  5. Contract starts
    1 Jan 2028

Notice history

2 events · 2 releases on Find a Tender · since 28 Nov 2025
  1. Preliminary market engagement notice published
    28 Nov 2025, 12:17 GMT
    UK2
  2. Preliminary market engagement notice published
    28 Nov 2025, 12:28 GMT
    UK2
Published amendments (1)

add link to portal

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

2 public bodies on the notice

The Royal Marsden NHS Foundation Trust

Contracting authorityPublic authority - central government GB-PPON: PXLT-9823-WVCY Fulham Road, London, London, SW3 6JJContact name, email

Other public bodies

Official documents & specifications (2)

Official links; attachments are not copied

Notices published for this procedure